Table 2.

Self-renewal analysis of human AML-CB cotransplants with or without mobilization treatment

AML Patient 3AML Patient 4AML Patient 5
Engraftment outcomesControlMobilizedControlMobilizedControlMobilized
AML only0/40/30/30/51/12/5
AML + CB4/43/32/31/50/12/5
CB only0/40/31/34/50/11/5
Total mice786
  • For each of three AML samples, it is indicated how many secondary transplant recipients were observed to have AML L-IC self-renewal, HSPC self-renewal, or both.